Improving Low Bone Mass With Vibration Therapy in Adolescent Idiopathic Scoliosis (AIS)

Phase 3

Completed

• Conditions: Scoliosis; Bone Diseases, Metabolic
• Interventions: Device: Vibration Platform

• Registration Number: NCT01108211
• Lead Sponsor: Chinese University of Hong Kong

Brief Summary

This is a prospective randomized controlled trial investigating the effect of vibration therapy on bone mineral density (BMD) and bone quality in AIS subjects suffering from osteopenia (low bone mass).

Detailed Description

Scoliosis is a three-dimensional spinal deformity and AIS is the commonest with a high prevalence of 2-4 % in the general population. As many as 30% of AIS subjects also suffer from osteopenia which can persist and result in serious health problems later in life including vertebral collapse, fragility fractures, decreased quality of life and even mortality. In spite of this, a safe, effective and evidence-based treatment protocol for AIS-related osteopenia is not available. It remains uncertain how effective dietary advices, physical activity, Calcium and Vitamin D supplements are in this regard. On the other hand, low-magnitude high-frequency vibration therapy was shown to be effective in increasing bone mass both in animal models and in clinical trials involving elderly subjects. AIS-related osteopenia may have a different clinical behaviour. In addition, the in-vivo effect on bone quality has never been studied. We plan to carry out a scientific clinical study on the effect of vibration therapy on skeletally mature female AIS subjects with osteopenia. They are randomly allocated to either the treatment or the control group. BMD, bone micro-architectures are assessed to delineate whether vibration therapy has any therapeutic effect on improving low bone mass in osteopenic AIS subjects.

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2010-04-19
• Study First Submitted QC: 2010-04-20
• Study First Posted: 2010-04-21
• Primary Completion: 2011-12
• Study Completion: 2011-12
• Status Verified: 2015-07
• Last Update Submitted: 2015-07-28
• Last Update Posted: 2015-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 149

Inclusion Criteria

• 15 to 25 year-old female patients suffering from clinically and radiologically diagnosed AIS
• more than 18 months post-menarche and Risser's sign equal to or greater than 4, and fusion of epiphyseal plate of all phalanges and metacarpals of the left hand and wrist.
• The Cobb's angle of the major structural curve is between 10 to 50 degrees (inclusive)
• Z-score BMD of less than -1

Read More

Exclusion Criteria

• medical or musculoskeletal conditions that contraindicate or prevent the patients from receiving vibration therapy
• subjects who are not willing to comply with the treatment protocol
• subjects suffering from any medical conditions that affect bone metabolism such as hyperparathyroidism, hyperthyroidism, osteomalacia, acute or chronic renal or liver disease
• treatment with medication that affects bone metabolism such as bisphosphonate, steroid.
• pregnancy
• history of spinal operation done for scoliosis
• smokers or drinkers

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment Group	Vibration Platform	This group will receive Vibration Therapy.

Primary Outcome Measures

Name	Time	Method
Bone mineral density	1 year

Secondary Outcome Measures

Name	Time	Method
Bone micro-architecture	1 year

Trial Locations

Locations (1)

Prince of Wales Hospital; 🇨🇳 Hong Kong SAR, Guangdong, China